Delcath Systems Inc

NASDAQ:DCTH   4:00:00 PM EDT
4.77
-0.32 (-6.29%)
4:00:06 PM EDT: $4.77 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)105.16M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.2 Million
Adjusted EPS-$0.47
See more estimates
10-Day MA$4.57
50-Day MA$4.35
200-Day MA$4.22
See more pivots

Delcath Systems Inc Stock, NASDAQ:DCTH

566 Queensbury Avenue, Suite 22C, Queensbury, New York 12804
United States of America
Phone: +1.212.489.2100
Number of Employees: 76

Description

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded in August 1988 and is headquartered in Queensbury, NY.